APA Awarded CMS Funding to Develop Quality Measures

Washington, D.C.– The American Psychiatric Association (APA) has been awarded funding to develop mental health and substance use quality measures as part of the Centers for Medicare and Medicaid Services’ (CMS) Quality Payment Program (QPP) established under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). APA is working with experienced measurement developer NCQA. The three-year funding was awarded by CMS who awarded funding to a total of seven organizations.

The Medicare Access and CHIP Reauthorization Act of 2015 authorized CMS to provide incentives that encourage physicians to focus on quality, value of care and patient health. This grant will help develop and improve quality measures for mental health and substance use disorders, including patient-reported outcomes, patient experience, care coordination and measures of appropriate use of services. The grant also aims to minimize the burden of measurement by eliminating redundancies and low-value quality measures from the QPP. APA will use PsychPRO registry, a CMS Qualified Clinical Data Registry, to test these quality measures as part of the grant.

“APA is proud to take a leading role in shaping quality measures for our field,” said APA CEO and Medical Director, Saul Levin, M.D., M.P.A. “This grant will help us ensure that patients are receiving the highest standards of psychiatric care and that providers can easily report and be reimbursed for providing high quality services.”

American Psychiatric Association

The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 37,800 physician members specializing in the diagnosis, treatment, prevention and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information please visit www.psychiatry.org.

Media Contacts

Erin Connors, 202-609-7113

Press Line, 202-459-9732